Safety and processing of two study drugs in healthy adults
Part of Heart & circulation clinical trials.
This study tests two new drugs in healthy adults to see how safe they are and how the body processes them. Taking part may help researchers learn if the drugs are safe for future use, though there is no direct benefit to you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 64 years old.
- Your body mass index (BMI) must be between 18 and 30.
- You must weigh at least 50 kilograms (about 110 pounds).
- You have not taken part in another clinical study of an experimental drug in the last 6 months.
- Other health checks will be done to make sure you are eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two forms of a new medicine to see how safe they are and how the body handles them. It is for healthy adults aged 19 to 64, and participation helps gather important early information before the drug is studied in patients.
This trial tests how two study drugs, AD-2321 and AD-2322, interact with each other in the body and checks if they are safe for healthy adults. Taking part will help researchers learn more about these drugs for future use.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
This study will compare two versions of a drug (called AD-117 and AD-117A) to see how your body processes them and whether they are safe. You would receive one version and then the other, to compare their effects.
This trial tests how three study drugs interact with each other in healthy adults. It may help find safe doses for future treatments.
This trial tests a new drug (AD-115A or AD-1151) in healthy volunteers to see how safe it is and how the body processes it. If you qualify, you'll receive a single dose and be monitored closely.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.